Hypothyroid Medication Recall Issued
A recall has been issued for nearly 40 types of thyroid medication. The medications recalled are levothyroxine (LT4) and liothyronine (LT3) in the 15, 30, 60, 90, and 120 milligrams dosages. The medications would have been sold in 100-count bottles.
According to CNN, the recall was voluntarily issued by the supplier, Westminster Pharmaceuticals, when their Chinese manufacturer failed an FDA inspection. The CEO of Westminster Pharmaceuticals, Gajan Mahendiran, issued a statement regarding the recall that read in part, “While we stand behind the quality of our product, we are taking the utmost precaution by recalling our Thyroid, USP Tablets only to the wholesale level due to a recent inspection by the FDA at one of our active ingredient manufacturers." Westminster insists that the recall is simply “out of an abundance of caution”, and not the result of anyone being sickened by the medications.
In spite of the recall, the FDA is not asking consumers to stop taking their thyroid medications. Due to the importance of the medications for many Americans, the FDA is recommending patients continue to take their thyroid prescription as normal “until they can contact their physician or pharmacist for further guidance.”
To read CNN’s full report, follow this link: https://cnn.it/2KYrIsw
For a complete breakdown on the recalled items, you can visit the FDA’s website here: https://bit.ly/2PpLKhY
Westminster Regulatory Affairs Department
Phone: 888-354-9939 (Monday – Friday)